It has been known that endothelin-1 (ET-1) exerts important actions in gastrointestinal smooth muscle motility, but its precise mechanism remains unsolved. We investigated the intracellular mechanism of ET-1-induced circular smooth muscle cell contraction in cat esophagus. ET-1 produced contraction of smooth muscle cells isolated by enzymatic digestion. The contraction in response to ET-1 was concentration-dependent. Pertussis toxin (PTX) blocked contraction induced by ET-1 in intact cells. To identify the specific G protein involved in the contraction, muscle cells were permeabilized with saponin. The G i3 or G ␤ protein antibody inhibited the contraction. Neomycin phospholipase C (PLC) inhibitor inhibited the contraction, but 7,7-dimethyleicosadienoic acid (phospholipase A 2 inhibitor) and p-chloromercuribenzoic acid (phospholipase D inhibitor) had no effects. Incubation of permeabilized cells with PLC-␤ 3 isozyme antibody inhibited the contraction. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine, chelerythrine [protein kinase C (PKC) inhibitor], or genistein (protein tyrosine kinase inhibitor) inhibited the contraction, but not by diacylglycerol (DAG) kinase inhibitor, R59949. To test whether the contraction may be PKC isozyme-specific, we examined the effect of PKC isozymes antibodies on the contraction. PKC-⑀ antibody inhibited the contraction. To characterize further the specific PKC isozymes that mediate the contraction, we used, as an inhibitor, Nmyristoylated peptides (myr-PKC) derived from the pseudosubstrate sequences of PKC-␣␤␥, -␣, -␦, or -⑀. myr-PKC-⑀ inhibited the contraction, confirming that PKC-⑀ isozyme is involved in the contraction. To examine whether mitogen-activated protein kinases (MAPKs) mediate the contraction, specific MAPK inhibitors [MAPK kinase inhibitor, PD98059, (2Ј-amino-3Ј-methoxyflavone), and p38 MAPK inhibitor, SB202190 (4-4-fluorophenyl) 2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole)] were used. PD98059 or SB202190 blocked the contraction. ET-1 increased the intensity of the detection bands identified by immunological methods as MAPK monoclonal p44/p42 peptides. PD98059 decreased the intensity of the detection bands compared with ET-1. In conclusion, ET-1-induced contraction in cat esophageal circular muscle cells depends on PTX-sensitive G i3 protein and PLC-␤ 3 isozyme, resulting in the activation of PKC-⑀-or protein-tyrosine kinase-dependent pathway, subsequently mediating the activation of p44/p42 MAPK or p38 MAPK pathway.
antibodies on the contraction. PKC-⑀ antibody inhibited the contraction. To characterize further the specific PKC isozymes that mediate the contraction, we used, as an inhibitor, Nmyristoylated peptides (myr-PKC) derived from the pseudosubstrate sequences of PKC-␣␤␥, -␣, -␦, or -⑀. myr-PKC-⑀ inhibited the contraction, confirming that PKC-⑀ isozyme is involved in the contraction. To examine whether mitogen-activated protein kinases (MAPKs) mediate the contraction, specific MAPK inhibitors [MAPK kinase inhibitor, PD98059, (2Ј-amino-3Ј-methoxyflavone), and p38 MAPK inhibitor, SB202190 (4-4-fluorophenyl) 2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole)] were used. PD98059 or SB202190 blocked the contraction. ET-1 increased the intensity of the detection bands identified by immunological methods as MAPK monoclonal p44/p42 peptides. PD98059 decreased the intensity of the detection bands compared with ET-1. In conclusion, ET-1-induced contraction in cat esophageal circular muscle cells depends on PTX-sensitive G i3 protein and PLC-␤ 3 isozyme, resulting in the activation of PKC-⑀-or protein-tyrosine kinase-dependent pathway, subsequently mediating the activation of p44/p42 MAPK or p38 MAPK pathway.
Endothelin-1 (ET-1) is a vasoconstrictor peptide originally derived from endothelial cells functioning as a local regulator of vascular tone and has been reported to possess a wide variety of other biological activities. Recent studies indicate the presence of endothelin-like immunoreactivity, endothelin-1 mRNA, and endothelin receptor in esophagus (Uchida et al., 1998a; Ohta et al., 2000) and colon (Inagaki et al., 1991) .
ET-1 has a potent pharmacological effect on gastrointestinal smooth muscle, but its mechanisms remain uncharacterized. In gastrointestinal tract, ET-1 causes contraction of the esophagus (Uchida et al., 1998a) , stomach (Allcock et al., 1995) , and intestines (Kitsukawa et al., 1994) . ET-1 plays a broader role in diverse physiological actions (Rubanyi and Polokoff, 1994) , localizes in the enteric nervous system (Takahashi et al., 1990) , and exerts important modulatory actions in gastrointestinal motility (Takahashi et al., 1990; Allcock et al., 1995) . Most of the actions of ET-1 in gastrointestinal tract are contractile and occur via its direct action at the smooth muscle (Kitsukawa et al., 1994) . It is also suggested that ET-1 levels are elevated in gastrointestinal disease (Rubanyi and Polokoff, 1994; Ohta et al., 2000) .
ET-1 activates multiple signaling systems in vascular smooth muscle, involving such effects as phospholipase C (PLC), phospholipase D (PLD), phospholipase A2 (PLA 2 ), and protein kinase (PKC) (Simonson and Dunn, 1990) . After binding to its G protein-coupled ET receptor, ET-1 stimulates PLC hydrolysis of phosphatidylinositol-4,5-bisphosphate (PIP 2 ), generating the two second-messengers inositol triphosphate (IP 3 ) and DAG.
Increased phosphorylation of proteins on tyrosine residues following ET-1 stimulation has been observed in vascular smooth muscle cells, implicating protein-tyrosine kinases (PTKs) and/or phosphatases in the responses to this peptide (Koide et al., 1992) . Initially, the role of tyrosine kinases in cell signaling was thought to be restricted to long-term effects such as growth and proliferation. However, it is now recognized that increased protein tyrosine phosphorylation occurs rapidly (within seconds) in response to both polypeptide growth factors and vasoconstrictor hormones (Abedi et al., 1995) . Furthermore, the observation that epidermal growth factor and platelet-derived growth factor increase vascular tone, an effect blocked by genistein and typhostins, both inhibitors of tyrosine kinases, supports the possibility that tyrosine phosphorylation is involved in the contractile response (Hollenberg, 1994) .
PKC is a family of homologous serine and threonine protein kinases. PKC is present in the cell cytoplasm and, upon agonist stimulation, rapidly translocates to the particulate or membrane fraction observed by Western immunoblot analysis and immunofluorescence studies (Sohn et al., 1997a,b) . Agonist-stimulated PKC location occurs coincidentally with Ca 2ϩ release from intracellular stores, but the specific role of increased cytosolic Ca 2ϩ in PKC activation is not known. The most direct evidence for PKC-mediated contraction is provided by studies in which active PKC-⑀ was injected into saponin-permeabilized ferret aorta smooth muscle cells (Horowitz et al., 1996a) . Active PKC-⑀ stimulates ferret aorta contraction, identical to phorbol ester-stimulated contraction, which is reversed by a PKC pseudosubstrate inhibitor. An earlier study revealed that Ca 2ϩ -independent contraction is preceded by translocation of PKC-⑀ from the cytosol to the plasma membrane (Khalil et al., 1992) .
The p44/42 MAP kinase (MAPK) pathway consists of a protein kinase cascade linking growth and differentiation signals with transcription in the nucleus. A selective and potent inhibitor of the p44/42 MAPK cascade, PD98059, has been identified (Payne et al., 1991) . As this compound does not inhibit the stress-activated protein kinase or p38 MAPK cascades, it will help to identify functional activities associated with MEK and p44/42 MAPK activation (Payne et al., 1991) . Recently, it was reported that ET-1 activates MAPK (Liang et al., 2000) , which is inhibited by PD98059.
To test whether ET-1-induced contraction is mediated via a G protein-, phospholipase isozyme-, PKC-, PTK-, or MAPKdependent pathway, we investigated the signals in mediating contraction induced by ET-1 in cat esophageal circular muscle cells.
Materials and Methods

Materials
DEDA, R59949, PD98059, and SB202190 were purchased from Calbiochem (San Diego, CA); G protein antibodies (G i1 , G i2 , G i3 , G q , G s , and G o ), PKC isozyme antibodies (␤II, ␥, and ⑀) and PLC isozymes antibodies (␤1, ␤3, and ␥1) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Phosphospecific p44/p42 monoclonal MAP kinase antibody was obtained from New England Biolabs (Beverly, MA); enhanced chemiluminescence agents were obtained from PerkinElmer Life Sciences (Boston, MA); nitrocellulose membrane was obtained from Bio-Rad (Hercules, CA); and SDS sample buffer was obtained from Owl Separation Systems (Woburn, MA). Selective myristoylated peptide inhibitors derived from pseudosubstrate sequences of PKC-␣ (myr-PKC-␣) or PKC-␣␤␥ (myr-PKC-␣␤␥) were gifts from Drs. D. A. Dartt and D. Zoukhri (Harvard Medical School, Boston, MA) . HEPES, endothelin-1, collagenase type F, ammonium persulfate, ponceau S, bovine serum albumin, leupeptin, aprotinin, ␤-mercaptoethanol, neomycin, pCMB, EGTA, EDTA, and other reagents were purchased from Sigma-Aldrich (St. Louis, MO).
Preparation of Dispersed Muscle Cells
Single muscle cells were isolated as previously described (Bitar and Makhlouf, 1982; Biancani et al., 1987) . Muscle strips were incubated overnight in normal potassium-HEPES buffer containing 1 mg/ml papain, 1 mM dithiothreitol, 1 mg/ml bovine serum albumin, and 0.5 mg/ml collagenase (type F, Sigma) and equilibrated with 95% O 2 -5% CO 2 to maintain pH 7.0 at 31°C. The composition of the normal potassium-HEPES buffer was 1 mM CaCl 2 , 250 M EDTA, 10 mM glucose, 10 mM HEPES, 4 mM KCl, 131 mM NaCl, 1 mM MgCl 2 , and 10 mM taurine. The next day we warmed up the tissue at room temperature for 30 min and incubated the tissue in a water bath at 31°C for 30 min. After incubation, the digested tissue was poured out over a 360-m Nitex filter, rinsed in collagenase-free HEPES buffer to remove any trace of collagenase, and then incubated in this solution at 31°C, gassed with 95% O 2 -5% CO 2 . The cells were allowed to dissociate freely for 10 to 20 min. Suspensions of single muscle cells were harvested by filtration through a 500-m Nitex mesh (Bitar and Makhlouf, 1982; Biancani et al., 1987) . Before beginning the experiment, the cells were kept at 31°C for at least 10 min to relax the cells. Throughout the entire procedure, care was taken not to agitate the fluid to avoid cell contraction in response to mechanical stress.
Preparation of Permeabilized Smooth Muscle Cells
Cells were permeabilized, when required, to diffuse the agents such as G protein antibodies or PLC isozyme antibodies or PKC antibody, which do not diffuse across the intact cell membrane. After completion of the enzymatic phase of the digestion process, the partly digested muscle tissue was washed with an enzyme-free cytosolic buffer of the following composition: 20 mM NaCl, 100 mM KCl, 5.0 mM MgSO 4 , 0.96 mM NaH 2 PO 4 , 1.0 mM EGTA, and 0.48 mM CaCl 2 , and 2% bovine serum albumin. The cytosolic buffer was equilibrated with 95% O 2 -5% CO 2 to maintain a pH of 7.2 at 31°C. Muscle cells dispersed spontaneously in this medium. The cytosolic buffer contained 0.48 mM CaCl 2 and 1 mM EGTA, yielding 0.18 M free Ca 2ϩ as calculated according to Fabiato and Fabiato (1979) . After dispersion, the cells were permeabilized by incubation for 5 min in cytosolic buffer that contained saponin (75 g/ml). After exposure to saponin, the cell suspension was spun at 350g, and the resulting pellet was washed with saponin-free modified cytosolic buffer that contained antimycin A (10 M), ATP (1.5 mM), and an ATP-regenerating system that consisted of creatine phosphate (5 mM) and creatine phosphokinase (10 units/ml). After the cells were washed free of saponin, they were resuspended in modified cytosolic buffer.
Measurement of Contraction by Scanning Micrometry
Contraction of isolated muscle cells was measured by scanning micrometry (Sohn et al., 1995) . An aliquot of cell suspension containing 10 4 muscle cells/ml was added to HEPES medium containing the test agents. The reaction was terminated by addition of formalin (10% final concentration). The length of 40 to 50 muscle cells treated with a contractile agent was measured at random by scanning micrometry, phase contrast microscope (model ULWCD 0.30; Olympus, Tokyo, Japan), and digital closed-circuit video camera (CCD color camera; Toshiba, Tokyo, Japan) connected to a Macintosh computer
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at ASPET Journals on October 17, 2017 jpet.aspetjournals.org (Apple, Cupertino, CA) with a software program, NIH Image 1.57 (National Institutes of Health, Bethesda, MD) compared with length of untreated cells. Contraction was expressed as the percentage decrease in mean cell length from control. The time course of contraction with agonists consists of peak contraction followed by a lower sustained plateau. Contraction in the present study refers to the initial peak contraction that occurred at 30 s with ET-1.
Phospho-MAP Kinase Western Blots. Previously frozen samples were homogenized in a buffer containing 20 mM Tris, 0.5 mM EDTA, 0.5 mM EGTA, 10 g/ml leupeptin, 10 g/ml aprotinin, and 10 mM ␤-mercaptoethanol (pH 7.5). Sample homogenates were then centrifuged for 10 min at 4°C, and the supernatants were collected. Aliquots were subjected to electrophoresis on a 10% SDS-polyacrylamide gel and transferred onto a nitrocellulose membrane. Membranes were blocked in PBS containing 5% dry milk for 2 h before an overnight incubation in a PBS solution containing 0.1% bovine serum albumin and a phosphospecific p44/p42 MAP kinase (Tyr-202/ Tyr-204) antibody. Membranes were washed using PBS containing 0.05% Tween 20 and then incubated with horseradish peroxidaseconjugated secondary antibody (dilution 1:2000) for 1 h. Immunoreactive bands were visualized by enhanced chemiluminescence. Developed films from enhanced chemiluminescence were scanned and analyzed using NIH Image software; care was taken to avoid saturation of exposures for densitometry.
Protein Determination. The protein concentration in each reaction vial was measured spectrophotometrically using the Bio-Rad assay (Bio-Rad Chemical Division, Richmond, CA). The absorption was monitored at a wavelength of 595 nm.
Data Analysis. Data are expressed as the mean Ϯ S.E.M. Statistical differences between means were determined by Student's t test.
Differences between multiple groups were tested using analysis of variance for repeated measures and checked for significance using the Scheffe F test.
Results
Endothelin-1-Induced Contraction of Isolated Smooth Muscle Cells.
It is known that ET-1 induces contraction in smooth muscle cells (Ibitayo et al., 1998; Wang and Bitar, 1998; Su et al., 1999) . ET-1 induced contraction of smooth muscle cells that peaked at 30 s (26.2 Ϯ 2.0% decrease in cell length from control) and was sustained for up to 30 min ( Fig. 1) , being decreased slowly. The response to ET-1 was concentration-dependent ( Fig. 2) . Freshly isolated smooth muscle cells were stimulated for 30 s with 10
Ϫ10
Mϳ10
Ϫ6 M. The maximal response was seen at 10 Ϫ7 M.
The Effect of Pertussis Toxin (PTX) on Contraction
Induced by ET-1. It has been shown that ET-1 has its own receptor coupled with PTX-sensitive G protein (Kasuya et al., 1992; Kimura et al., 1999) . The cells were preincubated for 60 min with PTX (400 ng/ml). PTX abolished contraction induced by ET-1 (10 Ϫ7 M), implying that contraction in cat esophagus smooth muscle cells activated by ET-1 was coupled to a pertussis toxin-sensitive G protein (Fig. 3) .
Characterization of G Protein Subtype-Coupled Receptor of ET-1. Previously, we have shown that G i1-2 , G 0 , G i3 , G ␤ (40 kDa), G s (46 kDa), and G q (42 kDa) proteins exist in cat esophageal cells (Sohn et al., 1995; Yang et al., 2000) . To identify the specific G protein involved in cat esophagus contraction, muscle cells were permeabilized with saponin preincubated in cytosolic medium containing G protein antibody (1:200) to allow diffusion of the antibodies into the cytosolic region of the cell membrane (Sohn et al., 1997a) . These antibodies block receptor-induced activation of G protein by binding to the terminal peptide region of G protein that interacts with the receptor. After permeabilization, the G i3 and G ␤ antibody inhibited contraction, but G i1-2 , G o , G q , and G s did not (Fig. 4) .
PLC-␤3 Mediates ET-1-Induced Contraction
ET-1-induced contraction of esophageal smooth muscle cells was not affected by PLA 2 inhibitor DEDA (10 Ϫ5 M) (Yang et al., 2000) and PLD inhibitor CMB (10 Ϫ5 M) (Sohn et al., 1993; Yang et al., 2000) , but was significantly abolished by PLC inhibitor neomycin (10 Ϫ5 M) (Sohn et al., 1993; Yang et al., 2000) that abolished phosphoinositide hydrolysis in cells (Fig. 5) . These results suggested that contraction of We previously showed that Western blot analysis of homogenates obtained from dispersed smooth muscle cells using polyclonal antibodies to PLC isozymes demonstrated the presence of immunoreactive protein bands corresponding to 150 kDa (PLC-␤1 and PLC-␤3 antibody) and 145 kDa (PLC-␥1 antibody) (Yang et al., 2000) .
Incubation of permeabilized circular muscle cells for 1 h with PLC-␤3-specific antibody (1:200) (Yang et al., 2000) inhibited ET-1-induced (10 Ϫ7 M) contraction (P Ͻ 0.05). No other PLC-specific antibodies had any significant effect on the contraction (Fig. 6) .
The Roles of Protein Kinase C and Tyrosine Kinase in ET-1-Induced Contraction. Cells were preincubated with either the tyrosine kinase inhibitor genistein (10 Ϫ5 M) for 20 min or the protein kinase C inhibitor H-7 for 15 min (10 Ϫ5 M) (Sohn et al., 1995; Uchida et al., 1998b) or chelerythrine (10 Ϫ5 M) (Yang et al., 2000) or DAG kinase inhibitor R59949 (10 Ϫ5 M) for 1 min, respectively, before the addition of ET-1. ET-1-induced contraction was inhibited by preincubation with genistein as follows: percentage decrease in cell length was 27.7 Ϯ 2.1 versus 9.8 Ϯ 2.3% and 10.3 Ϯ 2.3 versus 16.4 Ϯ 2.0% in the cells preincubated with H-7 and chelerythrine, respectively (Fig. 7) .
Inhibition of ET-1-Induced Contraction of Permeabilized Esophagus Cells by PKC Antibodies. We previously have shown that PKC isozymes, detected by Western blot analysis, including the PKC-␤II, -␥, and -⑀ isozymes, are present in the circular smooth muscle of the esophagus (Sohn et al., 1997b) . To test the theory that PKC-mediated contraction may be isozyme-specific, we examined the effect of PKC isozyme antibodies on contraction induced by ET-1. Figure 8 shows that ET-1-induced contraction of permeabilized esophagus cells was significantly inhibited, from 20.4 Ϯ 0.4 to 6.0 Ϯ 0.3, by antibodies raised against PKC-⑀ (1:200) (Cao et al., 2001) and not by antibodies raised against the PKC-␤II or -␥ isozyme.
Different N-Myristoylated Pseudosubstrate Peptides Inhibit ET-1-Induced Contraction of Esophagus. To characterize further the specific PKC isozymes that mediate contraction of the smooth muscle cell type, we used as an inhibitor N-myristoylated peptides derived from the pseudosubstrate sequences of PKC-␣␤␥, -␣, ␦, and -⑀ (myr-PKC-␣␤␥, myr-PKC-␣, myr-PKC-␦, and myr-PKC-⑀) and examined their effect on ET-1-induced contraction of intact esophagus smooth muscle cells. ET-1-induced contraction was inhibited by the myristoylated peptide corresponding to the pseudosubstrate sequence of PKC-⑀ and was not inhibited by myr-PKC-␣, myr-PKC-␦, myr-PKC-␣␤␥, and PKI (Fig.  9) . These data support the hypothesis that PKC-⑀ mediates contraction of esophagus.
The dose response of the N-myristoylated pseudosubstrate peptides on ET-1-induced contraction was examined (Fig.  10) . ET-1-induced contraction was dose dependently inhibited by myr-PKC-⑀ in the esophagus. (Sbrissa et al., 1997; Kimura et al., 1999) . We investigated the role of MAPK activation in cat esophageal smooth muscle contraction. To test which MAPK is involved in ET-1-induced contraction, we used specific MAPK inhibitors. Preincubation of PD98059, a p44/p42 MAPK inhibitor, for 30 min blocked the contraction induced by ET-1 in a concentration-dependent manner. The maximal inhibition was observed in 10 Ϫ5 M. Preincubation for 30 min SB202190, a p38 MAPK inhibitor, also inhibited ET-1-induced contraction (Fig.  11) . To determine whether the contractile effects of ET-1 are related to the activation of MAPK in isolated smooth muscle cells of cat esophagus, cells were stimulated with ET-1 and immunodetection of MAPK was performed. As shown in Fig. 12 , ET-1 (10 Ϫ7 M) induced an increase in the intensity of the detection bands identified by immunological methods as phosphospecific MAPK monoclonal p44/ p42 peptides. Preincubation of PD98059 for 30 min induced a decrease in the intensity of the detection bands as compared with ET-1-stimulated cells.
Discussion
The endothelins are a family of 21-residue peptides consisting of three structurally related isoforms called endothelin (ET)-1, ET-2, and ET-3 (Huggins et al., 1993) . Many of the details of the biosynthetic pathways involved in the production of mature ET isoforms remain to be elucidated. These mature, active forms are produced from the corresponding approximately 200-residue prepropolypeptides that are encoded by three separate genes. These prepropeptides are first processed by a furin-like processing protease into biologically inactive intermediates called big ET-1, -2, and -3 (Laporte et al., 1993) . Big endothelins are then proteolytically activated via cleavage at the common Trp21 residue by a highly spe- (Opgenorth et al., 1992) . The production of endothelins is tightly regulated at the level of mRNA transcription. Endothelins acts on two pharmacologically and molecularly distinct subtypes of the heptahelical superfamily of receptors called ETA and ETB receptors (Arai et al., 1990) . Both receptor subtypes are expressed in a wide variety of cell types, with distinct but partially overlapping tissue distributions.
It is suggested that ET-1, possibly produced by mucosal epithelial cells, is present in the rat gastrointestinal tract and causes contraction of gastrointestinal smooth muscles (Takahashi et al., 1990) . ET is thought to have important physiological and pathophysiological roles in both absorptive and secretory functions of the gastrointestinal mucosa. Rabbit gastric epithelial cells in culture produce ET-1, which can act in a paracrine manner on blood vessels and other tissues in the mucosa (Ota et al., 1991) . G i3 and PLC-␤3 Mediate ET-1-Induced Contraction. G proteins transduce ligands binding to a cell surface receptor into intracellular signals. ET receptors are coupled to PTX-sensitive G protein (Emala et al., 1999; Husain and Abdel-Latif, 1999; Kimura et al., 1999) . It has been reported that PTX, at 100 ng/ml, completely blocked the ET-1-induced MAPK activation in rat puerperal uterine contraction (Kimura et al., 1999) , and pretreatment of PTX caused a significant reduction of ET-1-induced contraction in porcine coronary artery smooth muscle (Kasuya et al., 1992) , Rasassociated MAPK activity in rat ventricular myocytes (Chiloeches et al., 1999) , and p38 MAPK activity in cat iris sphincter smooth muscle cells (Husain and Abdel-Latif, 1999). We found that PTX, which inactivates G i /G o proteins, blocked the ET-1-induced contraction, suggesting that ET receptor couples with the G i /G o families of PTX-sensitive G proteins, which are consistent with those observed in rat mesangial cells (Simonson and Dunn, 1990) , rat ventricular myocytes (Kelly et al., 1990) , and rat uterine myometrial cells (Kimura et al., 1999) .
The ␣ subunit of G protein contains the site(s) for NADdependent ADP ribosylation by bacterial toxin. Alpha subunits of G i classes contain sites susceptible to modification by PTX. We found that in esophageal muscle, contraction depended on ET receptors linked to PTX-sensitive G proteins, which activated phosphatidylinositol-specific PLC. This result suggests the possibility that they may involve activation of PLC by ␣ or ␤␥ subunits of a PTX-sensitive G protein such as G i . We previously used these antibodies to identify G proteins present in esophageal circular muscle by Western blot. G q (42 kDa), G i1 (40 kDa), G i2 (40 kDa), G i3 (40 kDa), G o (40 kDa), and G s (46 kDa) were detected (Sohn et al., 1995) . In addition, the same G protein antibodies were used to examine which G protein mediates the contractile response of esophageal muscle. We found that ET-1-induced contraction of esophageal muscles was inhibited by antibodies raised against the alpha subunits of G i3 . It is suggested that G ␤␥ protein is also involved in ET-1-induced contraction.
The phosphoinositide response elicited by ET-1 was dependent on the presence of extracellular Ca 2ϩ since its chelation resulted in a marked decrease in ET-1-stimulated inositol phosphate accumulation (Little et al., 1992; Garrido and Israel, 1999) . ET-1-induced PIP 2 breakdown was inhibited by neomycin, an inhibitor of PLC, which indicates that stimulation of phosphoinositide turnover constitutes one of the signaling pathways of ET-1 through the stimulation of a receptor-coupled PLC (Little et al., 1992; Garrido and Israel, release in skinned muscle strips of rabbit main pulmonary artery (Kobayashi et al., 1989) , intestinal circular muscle cells (Murthy and Makhlouf, 1995) , and rat aortic smooth muscle cells (Little et al., 1992) . Our data suggested that ET-1 induced contraction via PLC and was inhibited by preincubation of neomycin. Western blot analysis demonstrated the presence of immunoreactive protein bands corresponding to 150-kDa PLC-␤1, PLC-␤3 antibody, and 145-kDa PLC-␥1 antibody (Yang et al., 2000) . Permeabilization was used to examine the participation of PLC isozymes in ET-1-induced muscle contraction. Antibodies to PLC-␤3, similarly to rabbit intestine (Murthy and Makhlouf, 1991) , inhibited ET-1-induced contraction. PLC-␤1 and PLC-␥1 antibodies had no effect by themselves. This result supported the role of PLC-␤3 in mediating esophageal muscle contraction.
It has been suggested that ET-1 activates G q/11 proteins. In the smooth muscle cells of the porcine trachea, ET-1-induced contraction was mediated by activation of a PTX-insensitive G q / 11␣ subunit that resulted in stimulation of PLC (Croxton Fig. 12 . Immunoblotting of MAPK using p44/42 phosphospecific monoclonal antibody. Samples were prepared from isolated cat esophageal smooth muscle and stimulated with ET-1 (10 Ϫ7 M). A, at 30 s, ET-1 (10 Ϫ7 M) increased in the intensity of the detection bands, indicating an increase in MAPK activity. When cells were pretreated with 10 Ϫ5 M PD98059 for 30 min, the intensity of the detection bands was decreased as compared with ET-1. B, we measured the density of detection bands using the NIH Image program. Data are means Ϯ S.E. of three experiments (Student's t test; ૺ, P Ͻ 0.05 versus control; #, P Ͻ 0.05 versus ET-1). , 1998) . However, it has also been reported that ET-1 can activate G i/o proteins (Kasuya et al., 1992; Kimura et al., 1999) . It has been suggested that agonist-induced contraction caused the production of IP 3 via a PTX-sensitive G protein-coupled PLC, and this signaling mechanism might be involved in the generation of contractile responses (Yu et al., 1998; An et al., 1999) . Chan et al. (2000) reported that enhancement of G q -dependent signals by G i -coupled receptors required activated PLC-␤ and was mediated via the ␤␥-dimer released from the G i . It has been suggested that atrial natriuretic peptide or vasoactive intestinal peptide stimulated phosphoinositide hydrolysis, which was inhibited by PTX, and antibodies to phospholipase C-␤3 and G ␤ (Murthy et al., 2000) . Similarly, Yu et al. (1998) suggested that cholecystokinin contracts cat gallbladder muscle by stimulating PTXsensitive G i3 protein coupled with PLC-␤3, producing IP 3 and DAG. In the present study, our data showed that the contraction induced by ET-1 in esophageal smooth muscle cells was blocked by PTX and by anti-G i␣3 , anti-G ␤␥ -subunits, and anti-PLC-␤3-specific antibodies, suggesting that ET-1 receptors in esophagus muscle are selectively coupled to PLC-␤3 via both ␣-and ␤␥-subunits of G i3 proteins. These findings are in agreement with a previous study showing that A 1-adenosine receptors in intestinal muscle, P 2Y receptors in gastric muscle, and cholecystokinin receptors in gallbladder muscle are coupled with PLC-␤3 via ␣-and ␤␥-subunits of the G i3 protein Makhlouf, 1995, 1998; Yu et al., 1998) . It was also suggested that an agonist-independent, muscle type-specific signal transduction pathway existed in cat esophagus (Sohn et al., 1995) .
ET-1-Induced Contraction Was Mediated by a Protein Tyrosine Kinase-or Protein Kinase C-Dependent Pathway in Cat Esophagus. Many vasoconstrictor agonists increase protein tyrosine phosphorylation and extracellular signal-regulated kinase activity in smooth muscle preparations (Khalil et al., 1995; Ohanian et al., 1997) . Furthermore, tyrosine kinase inhibitors block agonist-induced contraction (Horowitz et al., 1996b; Watts et al., 1996; Ohanian et al., 1997) as does extracellular signal-regulated kinase inhibition (Sbrissa et al., 1997) , suggesting that this pathway is important for smooth muscle contraction. Evidence from studies with growth factor and ␣ 1 -adrenoceptor agonists suggests that activation of tyrosine kinases may be involved in contraction (Hollenberg, 1994) , although the mechanisms that regulate tyrosine kinase activity, and the point at which this pathway may be involved in a contractile response, remain unclear. Catalan et al. (1999) suggested that the effect of ET-1 on tyrosine phosphorylation was doseand time-dependent and caused a rapid tyrosine phosphorylation of three groups of proteins in the molecular mass range 70 to 100 kDa, 100 to 150 kDa, and 150 to 200 kDa. In this study, we investigated the regulation of tyrosine phosphorylation following ET-1 stimulation and the role of this pathway in the contractile response. Genistein is known as protein tyrosine kinase inhibitor, and its level is used from 1 to 30 M for inhibition (Liu and Sturek, 1996; Su et al., 1999) . Genistein reduced contraction in response to ET-1 in cat esophagus cells, suggesting that tyrosine kinases are involved in an ET-1-induced contraction pathway.
Eleven isozymes of PKC have been identified in mammalian tissues. These isozymes can be divided into three groups, depending on their calcium and phospholipid requirements for activation: classical or conventional PKCs (cPKC), including ␣, ␤I, ␤II, and ␥, which are calcium-and phospholipiddependent; new PKCs (nPKC), including ␦, ⑀, , , and , which are calcium-independent and phospholipid-dependent; and atypical PKC (aPKC), including and , which are calcium-and phospholipid-independent (Nishizuka, 1995) .
PKC is an enzyme activated by DAG, a second messenger produced by the PLC-catalyzed hydrolysis of PIP 2 . PIP 2 hydrolysis produces two signaling molecules, DAG and IP 3 . DAG is the physiological activator of the classical and novel isoforms of PKC (Nishizuka, 1995) , whereas IP 3 regulates intracellular Ca 2ϩ movements (Berridge, 1993) . DAG kinase has been suggested to play an essential role in attenuation of DAG signals in agonist-stimulated cells. DAG kinase, which phosphorylates DAG to phosphatidic acid, is divided into a membrane-bound and a soluble form. DAG kinase inhibitor increases PKC activity by blocking the phosphorylation of DAG to phosphatidic acid . In this study, we have shown that R59949, a DAG kinase inhibitor, did not increase the ET-1-induced contraction. This result suggests that DAG kinase does not play a role on the ET-1-induced contraction, so that other metabolic pathways might be activated. This point remains to be explored.
PKC has been implicated in the regulation of sustained agonist-induced contraction of various smooth muscle preparations. Khalil et al. (1992) have shown that Ca 2ϩ -independent isoform PKC-⑀ is involved in the Ca 2ϩ -independent contraction of ferret aorta smooth muscle cells. ET-1 also induces the rapid and transient translocation of PKC-⑀ immunoreactivity from the soluble to the particulate cell fraction. The subcellular distributions of PKC-␣ and PKC-are not influenced by endothelin (Jiang et al., 1996) . Jiang et al. (1996) suggested that endothelin induces a rapid and transient increase in the amplitude of the Ca 2ϩ . This is blocked by both phorbol 1-myristrate 13-acetate pretreatment to down-regulate PKC and the PKC inhibitor chelerythrine, suggesting that PKC-⑀ plays a critical role in endothelin receptor-dependent increases in intracellular Ca 2ϩ (Jiang et al., 1996) . We found that ET-1-induced contraction of smooth muscle cells was inhibited by the antibody PKC-⑀ in the esophagus. The mechanism through which these antibodies inhibit contraction is unclear.
All PKC isozymes contain an autoinhibitory sequence called the pseudosubstrate domain that is thought to interact with the catalytic domain to keep the enzyme inactivity in resting cells. Allosteric activators, such as DAG or phorbol esters, relieve this intramolecular control by inducing a conformational change in the molecule that liberates the substrate-binding domain from the pseudosubstrate, thereby activating the enzyme. Synthetic peptides based on the pseudosubstrate sequences of individual isozymes might be specific inhibitors because they exploit the substrate specificity of the enzyme without interfering with ATP binding. A recent approach uses modification of peptides by myristoylation to overcome the permeability barrier of plasma membrane (Sohn et al., 1997b ). In the current study, we demonstrated isozyme-specific inhibition of ET-1-induced contraction of intact smooth muscle cells from the esophagus. ET-1-induced contraction of esophagus cells was significantly inhibited by the myristoylated peptide corresponding to the pseudosubstrate sequence of PKC-⑀ (myr-PKC-⑀). In addition, the myristoylated peptide derived from the sequence of the endogenous inhibitor of cAMP-dependent protein kinase A, PKI, was used as a control for the sequence specificity of the inhibitory effect. PKI had no effect on ET-1-induced contraction of esophageal smooth muscle.
ET-1-Induced Contraction Is Mediated via MAP Kinase-Dependent Pathway. MAP kinase (MAPK) has been implicated in a signal-transduction cascade that regulates cell proliferation and differentiation in various cell types (Cobb et al., 1991) . In the present study, the occurrence of MAPK was confirmed by immunological studies. Using antiphosphospecific p44/p42 MAPK antibody, we were able to clearly demonstrate two forms of proteins with relative molecular masses of 42 and 44 kDa, which were in the same range of MAPK found in most tissues Yamada et al., 1995) . The activation of MAPK by ET-1 was rapid, within 30 s. Kimura et al. (1999) showed that ET-1-induced MAPK activation is neither extracellular Ca 2ϩ -nor intracellular Ca 2ϩ -dependent. It has been suggested that MAPK is activated during ␣-adrenoceptor agonist-induced contraction through a pathway that involved PKC-⑀ in ferret aorta vascular smooth muscle cells (Khalil and Morgan, 1993) . This Ca 2ϩ -independent contraction appears to be completely abolished by PKC inhibitors (Katsuyama and Morgan, 1993) and significantly diminished by tyrosine kinase inhibitors (Khalil et al., 1995) .
In colonic smooth muscle cells Yamada et al., 1995) , agonist-induced contraction involves a kinase cascade initiated by PKC and causing activation and redistribution of MAPK. Similarly, the present data indicate that an activation of MAPK may be involved in the ET-1-induced contraction. Clerk et al. (1994) showed that the activation of p42-and p44-MAPK is also coupled to the ET receptor. The maximum extent of phosphorylation of p42-MAPK elicited by ET-1 corresponds to approximately 50 to 60% of the total p42-MAPK pool. Activation of p42 and p44 MAPK by ET-1 followed more slowly (complete in 3-5 min). Phosphorylation of p42-MAPK occurred simultaneously with its activation (Clerk et al., 1994) .
In summary, ET-1-induced contraction in cat esophageal circular muscle cells depends on PTX-sensitive G i3 protein and PLC-␤3 isozyme, resulting in the activation of a PKC-⑀-or PTK-dependent pathway, which subsequently mediated the activation of a p44/p42 MAPK or p38 MAPK pathway. (Fig. 13) . 
